Aripiprazole Orally Disintegrating Tablets and Daclizumab Subcutaneous
Determining the interaction of Aripiprazole Orally Disintegrating Tablets and Daclizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aripiprazole
Brand name: Abilify, Abilify Discmelt, Abilify Maintena, Aristada, Abilify MyCite, Aristada Initio
Synonyms: Aripiprazole, ARIPiprazole
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aripiprazole Orally Disintegrating Tablets-Dacogen
- Aripiprazole Orally Disintegrating Tablets-Dacomitinib
- Aripiprazole Orally Disintegrating Tablets-Dactinomycin
- Aripiprazole Orally Disintegrating Tablets-Dactinomycin Injection
- Aripiprazole Orally Disintegrating Tablets-Dactinomycin Intravenous
- Aripiprazole Orally Disintegrating Tablets-Daklinza
- Daclizumab Subcutaneous-Aripiprazole Tablets
- Daclizumab Subcutaneous-Aripiprazole Tablets with Sensor
- Daclizumab Subcutaneous-Aripiprazole, ARIPiprazole Lauroxil
- Daclizumab Subcutaneous-Aristada
- Daclizumab Subcutaneous-Aristada Initio
- Daclizumab Subcutaneous-Aristada injection